Brief: WuXi Biologics Announces Acquisition Of 30% Equity Interest In Wuxi Vaccines
Aug 30 (Reuters) - WuXi Biologics (Cayman) Inc
2269.HK :
* DEAL FOR $108.5 MILLION
Further company coverage: 2269.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on WuXi Biologics (Cayman)
See all newsHong Kong stocks end higher on pharma, tech gains
Hong Kong stocks climb, led by pharmaceutical, tech stocks
CanSino leads HK-listed vaccine makers lower as BioNTech halts mRNA trial
WuXi Biologics H1 net profit up on margin expansion
Brief: WuXi Biologics Logs HY Net Profit Attributable RMB 2,439.8 Mln